Cigna pursues trade secrets in ‘non-competes’ dispute

Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Navigating the rising wave against non-competes

25 July 2023 Amid criticism against restrictive covenants such as non-competes, what can life sciences firms do to keep their trade secrets safe and defend against unfair competition, ask David Pardue, Patti Bartis, and Sarah Hutchins of Parker Poe.

Americas

AltaThera hits competitor with trade secret suit

1 September 2022 Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

article

Swiss scientist convicted for GSK trade secrets theft

3 May 2022 A scientist working in Switzerland has been convicted of conspiring with his sister and others to steal trade secrets from GlaxoSmithKline for the benefit of their respective biopharmaceutical ventures.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Cigna pursues trade secrets in ‘non-competes’ dispute

More on this story

Editor's picks

Editor's picks

More features